These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2551389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Isolation and identification of hemin as an endogenous Na+/K(+)-ATPase inhibitor from porcine blood cells.
    Yasuhara T, Mori M, Wakamatsu K, Kubo K.
    Biochem Biophys Res Commun; 1991 Jul 15; 178(1):95-103. PubMed ID: 1648917
    [Abstract] [Full Text] [Related]

  • 4. Endogenous "ouabain-like" activity in bovine plasma.
    Tal DM, Katchalsky S, Lichtstein D, Karlish SJ.
    Biochem Biophys Res Commun; 1986 Feb 26; 135(1):1-8. PubMed ID: 3006675
    [Abstract] [Full Text] [Related]

  • 5. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M, Lam TT, Inagami T.
    Biochemistry; 1988 Jun 14; 27(12):4244-53. PubMed ID: 2844224
    [Abstract] [Full Text] [Related]

  • 6. Binding of unsaturated fatty acids to Na+, K(+)-ATPase leading to inhibition and inactivation.
    Swarts HG, Schuurmans Stekhoven FM, De Pont JJ.
    Biochim Biophys Acta; 1990 May 09; 1024(1):32-40. PubMed ID: 2159804
    [Abstract] [Full Text] [Related]

  • 7. Identification of 11,13-dihydroxy-14-octadecaenoic acid as a circulating Na+/K(+)-ATPase inhibitor.
    Lichtstein D, Samuelov S, Gati I, Felix AM, Gabriel TF, Deutsch J.
    J Endocrinol; 1991 Jan 09; 128(1):71-8. PubMed ID: 1847965
    [Abstract] [Full Text] [Related]

  • 8. Identification of linoleic and oleic acids as endogenous Na+,K+-ATPase inhibitors from acute volume-expanded hog plasma.
    Tamura M, Kuwano H, Kinoshita T, Inagami T.
    J Biol Chem; 1985 Aug 15; 260(17):9672-7. PubMed ID: 2991258
    [Abstract] [Full Text] [Related]

  • 9. Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog.
    Tamura M, Harris TM, Higashimori K, Sweetman BJ, Blair IA, Inagami T.
    Biochemistry; 1987 May 19; 26(10):2797-806. PubMed ID: 3038164
    [Abstract] [Full Text] [Related]

  • 10. Identification of Na+,K+-ATPase inhibitors of volume-expanded hog plasma.
    Inagami T, Tamura M.
    Hypertension; 1987 Nov 19; 10(5 Pt 2):I108-12. PubMed ID: 2824359
    [Abstract] [Full Text] [Related]

  • 11. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
    Gonick HC, Weiler EW, Prins BA, Purdy RE.
    J Cardiovasc Pharmacol; 1993 Nov 19; 22 Suppl 2():S69-71. PubMed ID: 7508033
    [Abstract] [Full Text] [Related]

  • 12. Dimethyl sulfoxide inhibits renal Na(+)-K(+)-ATPase at a site different from ouabain and atrial peptides.
    Chiou S, Vesely DL.
    Life Sci; 1995 Nov 19; 57(10):945-55. PubMed ID: 7643719
    [Abstract] [Full Text] [Related]

  • 13. Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.
    Akagawa K, Hara N, Tsukada Y.
    J Neurochem; 1984 Mar 19; 42(3):775-80. PubMed ID: 6319608
    [Abstract] [Full Text] [Related]

  • 14. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ, Krampitz G, Bäcker A, Michel H, Krampitz G, Meyer-Lehnert H.
    Am J Hypertens; 1995 Jul 19; 8(7):753-60. PubMed ID: 7546503
    [Abstract] [Full Text] [Related]

  • 15. Characterization of fatty acid interaction with ouabain and vanadate binding to (Na+ + K+)-activated ATPase.
    Hansen O.
    Biochim Biophys Acta; 1989 Nov 17; 986(1):130-4. PubMed ID: 2554979
    [Abstract] [Full Text] [Related]

  • 16. [Purification of an endogenous inhibitor of sodium-potassium-ATPase].
    Cloix JF, Miller ED, Pernollet MG, Devynck MA, Meyer P.
    C R Seances Acad Sci III; 1983 Feb 07; 296(5):213-6. PubMed ID: 6303528
    [Abstract] [Full Text] [Related]

  • 17. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
    Boschi S, Borghi C, Munarini A, Costa FV, Lu ZR, deVries D, Ambrosioni E.
    Biochem Biophys Res Commun; 1990 Jun 15; 169(2):360-8. PubMed ID: 2162662
    [Abstract] [Full Text] [Related]

  • 18. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
    Tamura M, Lam TT, Inagami T.
    Biochem Biophys Res Commun; 1987 Dec 16; 149(2):468-74. PubMed ID: 2827643
    [Abstract] [Full Text] [Related]

  • 19. Purification and characterization of an (Na+ + K+)-ATPase proteolipid labeled with a photoaffinity derivative of ouabain.
    Collins JH, Forbush B, Lane LK, Ling E, Schwartz A, Zot A.
    Biochim Biophys Acta; 1982 Mar 23; 686(1):7-12. PubMed ID: 6279154
    [Abstract] [Full Text] [Related]

  • 20. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S, Fernandez PG, Longerich L, Gault H.
    Can J Cardiol; 1989 Mar 23; 5(5):249-54. PubMed ID: 2547501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.